Paul Heffernan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The generation of new medicinal products is both a contributor to global economic growth and a source of valuable benefits to human health. Given their direct responsibility for public health, regulatory authorities monitor closely both the development and exploitation of the underlying technologies and the products derived from them. The manner in which(More)
In light of Fodor & Plyshyn’s [FP98] critique of connectionist architectures as symbol manipulators, connectionists have responded by demonstrating that neural networks can perform symbol manipulation. Furthermore certain connectionist architectures demonstrate symbol manipulation in a manner different to that of traditional symbolic implementations. In(More)
The generation of new medicinal products is both a contributor to global economic growth and a source of valuable benefits to human health. Despite continuing medical advances, there are numerous diseases for which effective therapeutic options are either limited or absent.
The solar photovoltaic (PV) industry has potential to offer significant opportunities for investors, manufacturers and technology adopters. However, there are technological, market, and institutional forces that have slowed the industry's emergence and limited the contribution of PV electricity. This paper uses interviews with industry experts and company(More)
  • 1